Fig. 3From: Efficacy and safety of Sofosbuvir-containing regimens in patients co-infected with chronic hepatitis C virus and human immunodeficiency virus: a meta-analysisPlots of safety outcome (a Forest plot of discontinuation; b Forest plot of SAEs; c Forest plot of any AEs; d Forest plot of any AEs based on treatment therapy)Back to article page
